These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 22402719)

  • 1. [Sialic Acid supplementation therapy for distal myopathy with rimmed vacuoles].
    Nishino I; Noguchi S
    Brain Nerve; 2012 Mar; 64(3):255-61. PubMed ID: 22402719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Sialic acid supplementation therapy for distal myopathy with rimmed vacuoles (GNE myopathy)].
    Nishino I; Noguchi S
    Rinsho Shinkeigaku; 2012; 52(11):1210-2. PubMed ID: 23196566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Animal model of distal myopathy with rimmed vacuoles/hereditary inclusion body myopathy and preclinical trial with sugar compounds].
    Noguchi S; Malicdan MC; Nishino I
    Brain Nerve; 2010 Jun; 62(6):601-7. PubMed ID: 20548120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Molecular pathomechanism of distal myopathy with rimmed vacuoles].
    Nishino I; Noguchi S; Murayama K; Ohkuma A; Kasahata N; Malicdan MC; Hayashi YK; Nonaka I
    Rinsho Shinkeigaku; 2005 Nov; 45(11):943-5. PubMed ID: 16447769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Gne knockout mouse expressing human V572L mutation develops features similar to distal myopathy with rimmed vacuoles or hereditary inclusion body myopathy.
    Malicdan MC; Noguchi S; Nonaka I; Hayashi YK; Nishino I
    Hum Mol Genet; 2007 Jan; 16(2):115-28. PubMed ID: 17164266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Gne knockout mouse expressing human GNE D176V mutation develops features similar to distal myopathy with rimmed vacuoles or hereditary inclusion body myopathy.
    Malicdan MC; Noguchi S; Nonaka I; Hayashi YK; Nishino I
    Hum Mol Genet; 2007 Nov; 16(22):2669-82. PubMed ID: 17704511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Development of therapy for distal myopathy with rimmed vacuoles].
    Nishino I; Malicdan MC; Noguchi S
    Rinsho Shinkeigaku; 2009 Nov; 49(11):852-5. PubMed ID: 20030229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Sialic Acid Replacement Therapy for Distal Myopathy with Rimmed Vacuoles].
    Mori-Yoshimura M; Nishino I
    Brain Nerve; 2015 Sep; 67(9):1115-23. PubMed ID: 26329152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular pathomechanism of distal myopathy with rimmed vacuoles.
    Nishino I; Malicdan MC; Murayama K; Nonaka I; Hayashi YK; Noguchi S
    Acta Myol; 2005 Oct; 24(2):80-3. PubMed ID: 16550921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Efficacy of Aceneuramic Acid for Distal Myopathy with Rimmed Vacuoles].
    Aoki M; Izumi R; Suzuki N
    Brain Nerve; 2023 Oct; 75(10):1149-1154. PubMed ID: 37849366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sialyllactose ameliorates myopathic phenotypes in symptomatic GNE myopathy model mice.
    Yonekawa T; Malicdan MC; Cho A; Hayashi YK; Nonaka I; Mine T; Yamamoto T; Nishino I; Noguchi S
    Brain; 2014 Oct; 137(Pt 10):2670-9. PubMed ID: 25062695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety, pharmacokinetics and sialic acid production after oral administration of N-acetylmannosamine (ManNAc) to subjects with GNE myopathy.
    Xu X; Wang AQ; Latham LL; Celeste F; Ciccone C; Malicdan MC; Goldspiel B; Terse P; Cradock J; Yang N; Yorke S; McKew JC; Gahl WA; Huizing M; Carrillo N
    Mol Genet Metab; 2017 Sep; 122(1-2):126-134. PubMed ID: 28641925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Muscle weakness correlates with muscle atrophy and precedes the development of inclusion body or rimmed vacuoles in the mouse model of DMRV/hIBM.
    Malicdan MC; Noguchi S; Hayashi YK; Nishino I
    Physiol Genomics; 2008 Sep; 35(1):106-15. PubMed ID: 18628337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autophagy in a mouse model of distal myopathy with rimmed vacuoles or hereditary inclusion body myopathy.
    Malicdan MC; Noguchi S; Nishino I
    Autophagy; 2007; 3(4):396-8. PubMed ID: 17471014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hereditary inclusion-body myopathy: clues on pathogenesis and possible therapy.
    Broccolini A; Gidaro T; Morosetti R; Mirabella M
    Muscle Nerve; 2009 Sep; 40(3):340-9. PubMed ID: 19618441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of NCAM helps identify unusual phenotypes of hereditary inclusion-body myopathy.
    Broccolini A; Gidaro T; Tasca G; Morosetti R; Rodolico C; Ricci E; Mirabella M
    Neurology; 2010 Jul; 75(3):265-72. PubMed ID: 20644153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent advances in distal myopathy with rimmed vacuoles (DMRV) or hIBM: treatment perspectives.
    Malicdan MC; Noguchi S; Nishino I
    Curr Opin Neurol; 2008 Oct; 21(5):596-600. PubMed ID: 18769255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Therapeutic development for GNE myopathy.].
    Suzuki N; Izumi R; Kato M; Warita H; Aoki M
    Clin Calcium; 2017; 27(3):429-434. PubMed ID: 28232658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peracetylated N-acetylmannosamine, a synthetic sugar molecule, efficiently rescues muscle phenotype and biochemical defects in mouse model of sialic acid-deficient myopathy.
    Malicdan MC; Noguchi S; Tokutomi T; Goto Y; Nonaka I; Hayashi YK; Nishino I
    J Biol Chem; 2012 Jan; 287(4):2689-705. PubMed ID: 22157763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [GNE myopathy].
    Urtizberea JA; Béhin A
    Med Sci (Paris); 2015 Nov; 31 Spec No 3():20-7. PubMed ID: 26546927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.